Skip to main content
Clinical Trials/NCT02515253
NCT02515253CompletedNot Applicable

A Randomised Control Trial of an Individual Bra Prescription Versus Standard Care for Women With Larger Breasts and Breast Pain

University of Portsmouth2 sites in 1 country33 target enrollmentStarted: October 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
33
Locations
2
Primary Endpoint
Patient Global Impression of Change (PGIC)

Study Overview

Brief Summary

The purpose of this study is to assess whether prescribing a bra to participants results in an improvement in the Patient Global Impression of Change (PGIC) compared to participants who receive standard care alone.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Female, aged 18 years of age and above.
  • •Experiencing breast pain of any severity.
  • •Participants must be able to speak and read English fluently
  • •Participants must be a resident within the local area and not planning to move out of the area within the study timeline
  • •Participant must have attended the Queen Alexandra (QA) hospital for an assessment of their breast pain.
  • •Participant is willing and able to give informed consent for participation in the study.
  • •Participant is self-reported to be between a 34 and 40 under band size and a DD to G bra cup size.
  • •Able to walk on a treadmill for up to two minutes unaided and be able to walk unaided up and down a small set of steps (assessed verbally by the clinicians at QA hospital)
  • •Participants must be able to comply with the study procedures

Exclusion Criteria

  • •Participants are receiving any additional treatment for their breast pain that is not part of standard care (recommendation for a bra fit, topical ibuprofen, breast pain leaflet) including any cancer treatment
  • •Participants have had any surgery to the breasts within the last year
  • •Participants are currently pregnant or have been pregnant or breast fed in the past year
  • •Planning to undertake any activities or lifestyle changes which may affect their levels of breast pain e.g. trying for a baby, changing oral contraceptive, having breast surgery.
  • •Participant's data will be excluded from the analysis if they do not complete either survey at four or eight weeks (at least one follow up survey needs to be completed).

Arms & Interventions

Prescription group

Experimental

Participants in this group will receive the standard care for benign breast pain sufferers (administered by the Queen Alexandra Hospital in Portsmouth) and will also attend the Department of Sport and Exercise Science at the University of Portsmouth for an individual bra prescription. Participants will be prescribed an appropriate bra to wear over an eight week intervention period.

Intervention: Bra prescription (Other)

Prescription group

Experimental

Participants in this group will receive the standard care for benign breast pain sufferers (administered by the Queen Alexandra Hospital in Portsmouth) and will also attend the Department of Sport and Exercise Science at the University of Portsmouth for an individual bra prescription. Participants will be prescribed an appropriate bra to wear over an eight week intervention period.

Intervention: Standard Care (Other)

Standard care group

Other

Participants in this group will receive the standard care for benign breast pain sufferers administered by the Queen Alexandra Hospital in Portsmouth.

Intervention: Standard Care (Other)

Outcomes

Primary Outcomes

Patient Global Impression of Change (PGIC)

Time Frame: eight weeks post intervention

Participants will complete the PGIC as part of a questionnaire eight weeks after receiving their treatment for benign breast pain

Patient Global Impression of Change (PGIC)

Time Frame: four weeks post intervention

Participants will complete the PGIC as part of a questionnaire four weeks after receiving their treatment for benign breast pain 1. = Very much improved (better outcome) 2. = Much improved 3. = Minimally improved 4. = No change 5. = Minimally worse 6. = Much worse 7. = Very much worse (worse outcome)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Emma Burnett

PhD Research Student

University of Portsmouth

Study Sites (2)

Loading locations...

Similar Trials